Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HERAKLES: standard vs CNI-free vs CNI-low dose immunosuppression in de novo kidney transplant
DRKS00000014Phase 3Completed
- Sponsor
- Novartis
- Start
- Sep 2008
- Modality
- Small Molecules, Peptides
- Countries
- 2
01
Overview
A Phase 3 trial of cyclosporine in kidney transplant immunosuppression, sponsored by Novartis. Started Sep 2008; status: completed.
02
Drugs
cyclosporine
03
Conditions
kidney transplant immunosuppression
Beyond the preview
Go deeper on DRKS00000014.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00000014.